Agenus
AGEN
#8503
Rank
A$0.40 B
Marketcap
A$9.84
Share price
-7.08%
Change (1 day)
35.01%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): A$0.17 Billion

According to Agenus 's latest financial reports the company's current earnings are A$0.12 Billion. In 2025 the company made an earning of A$73.81 Million, an increase over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.17 B139.93%
2025 A$73.81 M-145.52%
2024 -A$0.17 Billion-28.13%
2023 -A$0.23 Billion-5.5%
2022 -A$0.24 Billion-556.26%
2021 A$52.32 M-130.37%
2020 -A$0.18 Billion73.75%
2019 -A$99.16 Million-48.74%
2018 -A$0.2 Billion34.32%
2017 -A$0.15 Billion-7.16%
2016 -A$0.16 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$58.31 Million49.12%
2013 -A$39.1 Million
2011 -A$27 Million-12.25%
2010 -A$30.77 Million-21.41%
2009 -A$39.15 Million-26.86%
2008 -A$53.53 Million13.72%
2007 -A$47.07 Million-33.4%
2006 -A$70.67 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$94.48 Million-0.8%
2003 -A$95.25 Million17.37%
2002 -A$81.15 Million37.83%
2001 -A$58.88 Million55.99%
2000 -A$37.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.60 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.15 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.44 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA